Over the past year panCELLa has enhanced its patent position and expanded access to its exclusive FailSafeTM and induced Allogeneic Cell Tolerance (iACT Stealth CellsTM ). panCELLa continues to accelerate cell-based...
panCELLa, a privately held biotechnology company focused on developing safe therapeutic cell products for a broad range of diseases, is pleased to announce the issuance of the FailSafeTM patent in Japan. This patent is...
“Regenerative medicine is at a point now where we can translate our research into therapies that can help all humankind,” (Dr. Andras Nagy) Stem cell pioneer Andras Nagy has a way of describing the work of your...